<!DOCTYPE html>
<html lang="en-US"><head>
		<meta charset="UTF-8">
		<title>FR940208-2-00047</title>
	</head>
	<body>
		<main>
			<p><!-- PJG ITAG l=10 g=1 f=2 --> EFFECTIVE DATE: <!-- PJG /ITAG -->  <!-- PJG ITAG l=10 g=1 f=1 -->  February 18, 1994 <!-- PJG /ITAG -->  <!-- PJG QTAG 02 --> <!-- PJG /QTAG -->  <!-- PJG 0012 frnewline --> <!-- PJG STAG 4703 -->  <!-- PJG ITAG l=94 g=1 f=1 -->  <!-- PJG /ITAG -->  <!-- PJG ITAG l=69 g=1 f=1 -->  <!-- PJG /ITAG -->  <!-- PJG ITAG l=50 g=1 f=1 -->   <USDEPT>DEPARTMENT OF HEALTH AND HUMAN SERVICES</USDEPT>  <!-- PJG /ITAG -->  <!-- PJG ITAG l=18 g=1 f=1 -->  <USBUREAU>Food and Drug Administration</USBUREAU> <!-- PJG 0012 frnewline -->  <!-- PJG /ITAG -->  <!-- PJG ITAG l=41 g=1 f=1 -->  <RINDOCK>[Docket No. 93N&hyph;0460]</RINDOCK> <!-- PJG 0012 frnewline -->  <!-- PJG /ITAG -->  <!-- PJG ITAG l=52 g=1 f=1 -->  <DOCTITLE>Wyeth-Ayerst Laboratories, et al.; Withdrawal of Approval of NADA's</DOCTITLE> <!-- PJG 0012 frnewline -->  <!-- PJG /ITAG -->  <AGENCY> <!-- PJG ITAG l=10 g=1 f=2 --> AGENCY: <!-- PJG /ITAG -->  <!-- PJG ITAG l=10 g=1 f=1 -->  Food and Drug Administration, HHS. <!-- PJG /ITAG -->  <!-- PJG QTAG 02 --> <!-- PJG /QTAG -->  <!-- PJG 0012 frnewline --> </AGENCY> <ACTION> <!-- PJG ITAG l=10 g=1 f=2 --> ACTION: <!-- PJG /ITAG -->  <!-- PJG ITAG l=10 g=1 f=1 -->  Notice. <!-- PJG 0012 frnewline -->  <!-- PJG /ITAG -->  <!-- PJG ITAG l=59 g=1 f=1 -->  <!-- PJG 0012 frnewline -->  <!-- PJG /ITAG --> </ACTION> <SUMMARY> <!-- PJG ITAG l=10 g=1 f=2 --> SUMMARY: <!-- PJG /ITAG -->  <!-- PJG ITAG l=10 g=1 f=1 -->  The Food and Drug Administration (FDA) is withdrawing approval of four new animal drug applications (NADA's) held by Wyeth-Ayerst Laboratories, Pharmachem Corp., Sanofi Animal Health, Inc., and Squire Laboratories, Inc. The sponsors notified the agency in writing that the animal drug products are no longer marketed and requested that approval of the applications be withdrawn. In a final rule published elsewhere in this issue of the  <!-- PJG /ITAG -->  <!-- PJG ITAG l=10 g=1 f=4 --> Federal Register <!-- PJG /ITAG -->  <!-- PJG ITAG l=10 g=1 f=1 --> , FDA is amending the regulations by removing the entries which reflect approval of the NADA's. <!-- PJG /ITAG -->  <!-- PJG QTAG 02 --> <!-- PJG /QTAG -->  <!-- PJG 0012 frnewline --> </SUMMARY> <DATE> <!-- PJG ITAG l=10 g=1 f=2 --> EFFECTIVE DATE: <!-- PJG /ITAG -->  <!-- PJG ITAG l=10 g=1 f=1 -->  February 18, 1994 <!-- PJG /ITAG -->  <!-- PJG QTAG 02 --> <!-- PJG /QTAG -->  <!-- PJG 0012 frnewline --> </DATE> <FURTHER> <!-- PJG ITAG l=10 g=1 f=2 --> FOR FURTHER INFORMATION CONTACT: <!-- PJG /ITAG -->  <!-- PJG ITAG l=10 g=1 f=1 -->  Mohammad I. Sharar, Center for Veterinary Medicine (HFV&hyph;216), Food and Drug Administration, 7500 Standish Pl., Rockville, MD 20855, 301&hyph;594&hyph;0749. <!-- PJG /ITAG -->  <!-- PJG QTAG 02 --> <!-- PJG /QTAG -->  <!-- PJG 0012 frnewline --> </FURTHER> <SUPPLEM> <!-- PJG ITAG l=10 g=1 f=2 --> SUPPLEMENTARY INFORMATION: <!-- PJG /ITAG -->  <!-- PJG ITAG l=10 g=1 f=1 -->  The sponsors of the NADA's listed in the table in this document have informed FDA that these animal drug products are no longer marketed or distributed and have requested that FDA withdraw approval of the applications.  <!-- PJG 0012 frnewline -->  <!-- PJG /ITAG -->  <TABLE>  <!-- PJG tableformat 3,L2,i1,s50,r70,r70 -->  <!-- PJG 0012 frnewline -->  <!-- PJG 007 0150 intable --> 1NADA No. <!-- PJG 0012 frnewline -->  <!-- PJG 007 0150 intable --> 1Drug <!-- PJG 0012 frnewline -->  <!-- PJG 007 0150 intable --> 1Sponsor <!-- PJG 007 0152 intable -->  <!-- PJG 0012 frnewline -->  <!-- PJG ITAG l=01 g=1 f=1 --> 10&hyph;783 <!-- PJG 0012 frnewline -->  <!-- PJG 007 0104 intable --> Promazine hydrochloride tablets <!-- PJG 0012 frnewline -->  <!-- PJG 007 0104 intable --> Wyeth-Ayerst  <!-- PJG 0012 frnewline --> Laboratories P.O. Box 8299, Philadelphia., PA 19101 <!-- PJG 0012 frnewline --> 11&hyph;871 <!-- PJG 0012 frnewline -->  <!-- PJG 007 0104 intable --> Iron dextran injectable <!-- PJG 0012 frnewline -->  <!-- PJG 007 0104 intable --> Pharmachem Corp., P.O. Box 1035, Bethlehem, PA 18018 <!-- PJG 0012 frnewline --> 132&hyph;137 <!-- PJG 0012 frnewline -->  <!-- PJG 007 0104 intable --> Nitrofurazone solution <!-- PJG 0012 frnewline -->  <!-- PJG 007 0104 intable --> Sanofi Animal Health, Inc., 7101 College Blvd., suite 610, Overland Park, KS 66210 <!-- PJG 0012 frnewline --> 138&hyph;455 <!-- PJG 0012 frnewline -->  <!-- PJG 007 0104 intable --> Nitrofurazone solution <!-- PJG 0012 frnewline -->  <!-- PJG 007 0104 intable --> Squire  <!-- PJG 0012 frnewline --> Laboratories, Inc., 100 Mill St., Revere, MA 02151 <!-- PJG /ITAG -->  </TABLE>  <!-- PJG 0012 frnewline -->  <!-- PJG ITAG l=11 g=1 f=1 --> Therefore, under authority delegated to the Commissioner of Food and Drugs (21 CFR 5.10) and redelegated to the Center for Veterinary Medicine (21 CFR 5.84), and in accordance with &sect;514.115  <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=3 --> Withdrawal of approval of applications <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=1 -->  (21 CFR 514.115), notice is given that approval of NADA's 10&hyph;783, 11&hyph;871, 132&hyph;137, and 138&hyph;455 and all supplements and amendments thereto is hereby withdrawn, effective February 18, 1994. <!-- PJG 0012 frnewline --> In a final rule published elsewhere in this issue of the  <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=4 --> Federal Register <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=1 --> , FDA is removing the text of and reserving 21 CFR 520.1962(b) and amending 21 CFR 524.1580d(b) to reflect the withdrawal of approval of NADA's 10&hyph;783 and 138&hyph;455, respectively. It is unnecessary to amend the regulations to reflect withdrawal of approval of the other two NADA's because NADA 11&hyph;871 was never codified and the sponsor of NADA 132&hyph;137 (Sanofi) has been previously removed from the regulation. <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline -->  <!-- PJG /ITAG -->  <!-- PJG QTAG 04 --> <!-- PJG /QTAG -->  <!-- PJG 0012 frnewline -->  <!-- PJG ITAG l=21 g=1 f=1 --> Dated: January 31, 1994. <!-- PJG 0012 frnewline -->  <!-- PJG /ITAG --> </SUPPLEM> <SIGNER> <!-- PJG ITAG l=06 g=1 f=1 --> Richard H. Teske, <!-- PJG 0012 frnewline -->  <!-- PJG /ITAG --> </SIGNER> <SIGNJOB> <!-- PJG ITAG l=04 g=1 f=1 --> Acting Director, Center for Veterinary Medicine. <!-- PJG 0012 frnewline -->  <!-- PJG /ITAG --> </SIGNJOB> <FRFILING> <!-- PJG ITAG l=40 g=1 f=1 --> [FR Doc. 94&hyph;2755 Filed 2&hyph;7&hyph;94; 8:45 am] <!-- PJG 0012 frnewline -->  <!-- PJG /ITAG --> </FRFILING> <BILLING> <!-- PJG ITAG l=68 g=1 f=1 --> BILLING CODE 4160&hyph;01&hyph;F <!-- PJG /ITAG --> </BILLING>  <!-- PJG /STAG --></p>
		</main>
</body></html>
            